Robert Wessman is the founder, CEO and executive chairman of Alvogen, a privately owned global pharmaceutical company that develops, manufactures and markets generic, brand-name, over-the counter (OTC) and biosimilar medicines world-wide.
The Alvogen story began in June 2009, when Robert met prospective investors in a restaurant in New York and outlined on a napkin (which he still has) his vision for a new kind of pharmaceuticals business. Today, Alvogen offers high-quality, affordable medications to patients around the world, improving the quality and lowering the cost of healthcare for millions of people. Alvogen has 1,700 employees globally and commercial operations in the United States, China, Iceland, India, Luxembourg, Malaysia, Philippines, Singapore, South Korea, Vietnam, and a dozen other countries. Its offices in the US and South Korea serve as regional hubs, with specialized manufacturing and R&D capabilities.
The Alvogen product portfolio comprises leading therapeutic molecules in fields ranging from antivirals, cardiology, neurology and oncology to respiratory, addiction and gastroenterology. The company focuses its efforts on complex, first-to-market generics and differentiated brands. Alvogen has launched a number of products that have had a pioneering impact on broadening access to affordable and high-value medications to patients around the world. It was first to introduce a generic version of a critical antiviral used to combat influenza, and to offer an affordable version of a key transdermal treatment for Alzheimer's disease. The company remains committed to making the highest-quality medicines available to the patients who need them, whoever and wherever they are.
Powered by this purpose, Alvogen also has a deeply ingrained passion for performance and growth. This drive has propelled the company to its leading position, driving innovation and access atop an ever-changing industry. The company’s culture is built around finding solutions to big challenges and unmet medical need, and adapting the organization to best serve the evolving needs of its customers.
Alvogen believes that one key to making a better world is to provide everyone with affordable access to life changing medications. There is an urgent need to deliver the highest quality of products and services to patients around the world and it is this urgency that motivates and inspires us every day. Our mission has always been and remains to make a meaningful difference to people's lives and set a new standard in the pharmaceutical industry.
